Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2025 16:05 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Vispa-cel (CB-010) ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for outpatient use, highlighting its potential as a best-in-class...
November 11, 2025 04:58 ET | Source: SNS Insider pvt ltd

Phosphoramidite Market Size to Reach USD 2.14 Billion by 2032 Due to Gene Editing and mRNA Growth – SNS Insider

Austin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Phosphoramidite Market Size & Growth Analysis According to SNS Insider, the global Phosphoramidite Market was valued at USD 1.18 billion in 2024 and is...
November 10, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
October 29, 2025 14:12 ET | Source: BCC Research LLC

mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030

Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
October 16, 2025 07:00 ET | Source: Endure Biotherapeutics, Inc.

National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)

San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics, today announced that its founding discovery...
October 02, 2025 13:00 ET | Source: DelveInsight Business Research LLP

CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

New York, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight CRISPR therapies offer...
September 29, 2025 07:44 ET | Source: Research and Markets

Biochemicals Global Market Report 2026-2036: From ADM and BASF to Startups Like Ginkgo Bioworks: Biochemicals Market to Revolutionize Chemical Industry by 2036

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Global Biochemicals Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global biochemicals market represents one of...
September 26, 2025 07:12 ET | Source: Research and Markets

Base Editing Market Analysis 2025-2033 by Products & Services (Platform, gRNA Design), Application (Drug Discovery & Development), Type (DNA Base, RNA Base)

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery &...
August 29, 2025 04:18 ET | Source: Research and Markets

CRISPR Therapeutics: A New Era in Infectious Disease Management

Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Gene Editing in Infectious Diseases: Market Overview" report has been added to ResearchAndMarkets.com's offering.The report provides an...
August 25, 2025 16:05 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

BERKELEY, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...